(Q36194610)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16019478%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

review article

1 reference

title

Infliximab chimeric antitumor necrosis factor-a monoclonal antibody as potential treatment for myelodysplastic syndromes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16019478%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16019478%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

3

Adrian C Newland

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16019478%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

4

Drew Provan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16019478%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1

Roberto Stasi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16019478%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 April 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16019478%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16019478%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16019478%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16019478%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

509-516

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16019478%20AND%20SRC:MED&resulttype=core&format=json

Molecular mechanisms of myelodysplastic syndrome

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190400027829

Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400027829

Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400027829

Correlation of tumor necrosis factor alpha (TNF alpha) with high Caspase 3-like activity in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400027829

Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400027829

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400027829

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400027829

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400027829

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400027829

New indications for treatment of chronic inflammation by TNF-alpha blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400027829

BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400027829

Overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400027829

Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400027829

Angiogenesis in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400027829

Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400027829

The role of angiogenesis in hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400027829

Matrix metalloproteinase inhibitor reduces apoptosis induction of bone marrow cells in MDS-RA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400027829

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400027829

Metalloproteinase-mediated release of human Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400027829

Thalidomide as an anti-TNF-alpha inhibitor: implications for clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400027829

Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400027829

The clinical and biological effects of thalidomide in patients with myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400027829

Anti-tumor necrosis factor therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400027829

Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400027829

Tumor necrosis factor-alpha blockade for the treatment of acute GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400027829

Remicade as TNF suppressor in patients with myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400027829

Processing of tumour necrosis factor-α precursor by metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190400027829

10.1080/10428190400027829

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16019478%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference